A STUDY ON ASSESSMENT OF KNOWLEDGE, ATTITUDE AND PRACTICE REGARDING PHARMACOVIGILANCE AMONG HEALTHCARE PROFESSIONALS IN A TERTIARY CARE HOSPITAL, ANDHRA PRADESH

被引:2
作者
Komaram, Ravi Babu [1 ]
Dhar, Midan [1 ]
机构
[1] GSL Med Coll & Gen Hosp, Dept Pharmacol, Rajahmundry, Andhra Prades, India
关键词
Adverse Drug Reaction; Pharmacovigilance; Healthcare Professionals;
D O I
10.13040/IJPSR.0975-8232.7(12).5082-87
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: The aim of this study was to assess knowledge, attitude and practice of the healthcare professionals about Pharmacovigilance in a tertiary care hospital, Rajahmundry, Andhra Pradesh. Materials and Methods: A cross-sectional questionnaire based study was carried out on healthcare professionals (Faculties, Postgraduates, Interns & Nurses) to assess the knowledge, attitude and practice regarding Pharmacovigilance. Those who gave their consent to participate were included in the study. The obtained data was analyzed using the Statistical Package for Social Sciences (SPSS) statistical software, version 21. Qualitative variables were expressed as percentages and Chi-square test was used to compare the difference in correct responses for each question. For all statistical analysis p < 0.05 was considered statistically significant. Results: 290 pretested questionnaires were distributed among the participants, out of whom 272 responded. The study results showed that more than 55% of the study participants had knowledge and attitude regarding Pharmacovigilance but in the matter of practice of Pharmacovigilance less percentage of participants had experience. A major difference was noted between ADR (Adverse drug reaction)-experienced (65.81 %) and ADR-reported (23.9 %) individuals. Conclusion: This study demonstrated that knowledge and attitude towards Pharmacovigilance is gradually improving among healthcare professionals, but unfortunately the actual practice of ADR reporting is still lacking among them. Hence, strengthening of such practice will help in the future success of Pharmacovigilance programmes.
引用
收藏
页码:5082 / 5087
页数:6
相关论文
共 19 条
[1]  
Bismas P, 2007, INDIAN J PHARMACOL, V39, P124
[2]   Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality [J].
Classen, DC ;
Pestotnik, SL ;
Evans, RS ;
Lloyd, JF ;
Burke, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :301-306
[3]  
Desai Chetna K, 2011, Perspect Clin Res, V2, P129, DOI 10.4103/2229-3485.86883
[4]   STIMULATING REPORTING OF ADVERSE DRUG-REACTIONS BY USING A FEE [J].
FEELY, J ;
MORIARTY, S ;
OCONNOR, P .
BRITISH MEDICAL JOURNAL, 1990, 300 (6716) :22-23
[5]  
GUPTA P, 2011, J PHARM SCI RES, V3, P1064
[6]   Pharmacovigilance: current status & future challenges [J].
Gupta, S. K. .
INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2013, 4 (01) :1-4
[7]  
Gupta Sandeep Kumar, 2015, Perspect Clin Res, V6, P45, DOI 10.4103/2229-3485.148816
[8]   A Survey on the Knowledge, Attitude and the Practice of Pharmacovigilance Among the Health Care Professionals in a Teaching Hospital in Northern India [J].
Hardeep ;
Bajaj, Jagminder Kaur ;
Kumar, Rakesh .
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (01) :97-99
[9]  
Khan Sarfaraz Alam, 2013, J Nat Sci Biol Med, V4, P191, DOI 10.4103/0976-9668.107289
[10]  
Meher Bikash Ranjan, 2015, Perspect Clin Res, V6, P217, DOI 10.4103/2229-3485.167102